Experimental Cancer Drug Eliminates Tumors Safely
TL;DR Summary
A redesigned CD40 antibody drug, tested in a small clinical trial, has shown promising results by shrinking or eliminating tumors in some patients with metastatic cancers, with fewer side effects than previous versions, and appears to activate a systemic immune response.
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
5 min
vs 6 min read
Condensed
96%
1,081 → 41 words
Want the full story? Read the original article
Read on SciTechDaily